Work in the medical field is going to be done in a number of different ways and typical procedures, at least the first few times around, are done with mice. They are able to react to certain treatments in particular ways, which gives a good idea of how humans are going to react to certain therapies. That being said, how can brain tumor research expand in such a way? It's a point to take into account and a recent story on the matter was successful in grabbing my attention.
Science Daily posted an article about how John Hopkins researchers have been utilizing mice for the sake of testing an FDA-approved drug. It's relevant to brain tumor research because the mice in question had human tumor cells within them. After the administration of such a drug was done, the growth of such tumors have stopped before there was no trace being found as well. It's the kind of story worth focusing on by organizations such as Voices against Brain Cancer, as you could probably imagine.
The story went into detail about a mutation that was spotted within the IDH1 gene in 2008. For those who do not know what this gene entails, it is a rather common element that has been seen in about 70 to 80 percent of lower-grade tumors. With this mutation, the brain has difficulty bringing glucose into effect, transitioning it to an energy form so that the body can utilize it. It's apparent that there are challenges when you're talking about this field in particular and it's not hard to see why.
Everyone is going to be different in terms of the condition they have, meaning that different methods are going to be set in place. Tumors may be prevalent but the specific types couldn't be more different from one another in terms of how they are structured. Many different components can be brought into account in order to help research along. Knowing that there is a chance for these tumor cells to slow own before ultimately fading away brings a sense of hope to this matter in the medical field.
In my eyes, brain tumor research is one of those fields that have so much attention brought to it for the right reasons. Finding solid cures has proven to be a challenge but therapies seem to be built more and more over the course of time. It seems like some of them have proven to be successful, which has the case with this particular trial. Whether or not this will translate into human use remains to be seen but I am confident that results will rise to the surface.
Science Daily posted an article about how John Hopkins researchers have been utilizing mice for the sake of testing an FDA-approved drug. It's relevant to brain tumor research because the mice in question had human tumor cells within them. After the administration of such a drug was done, the growth of such tumors have stopped before there was no trace being found as well. It's the kind of story worth focusing on by organizations such as Voices against Brain Cancer, as you could probably imagine.
The story went into detail about a mutation that was spotted within the IDH1 gene in 2008. For those who do not know what this gene entails, it is a rather common element that has been seen in about 70 to 80 percent of lower-grade tumors. With this mutation, the brain has difficulty bringing glucose into effect, transitioning it to an energy form so that the body can utilize it. It's apparent that there are challenges when you're talking about this field in particular and it's not hard to see why.
Everyone is going to be different in terms of the condition they have, meaning that different methods are going to be set in place. Tumors may be prevalent but the specific types couldn't be more different from one another in terms of how they are structured. Many different components can be brought into account in order to help research along. Knowing that there is a chance for these tumor cells to slow own before ultimately fading away brings a sense of hope to this matter in the medical field.
In my eyes, brain tumor research is one of those fields that have so much attention brought to it for the right reasons. Finding solid cures has proven to be a challenge but therapies seem to be built more and more over the course of time. It seems like some of them have proven to be successful, which has the case with this particular trial. Whether or not this will translate into human use remains to be seen but I am confident that results will rise to the surface.
About the Author:
Visit Voices Against Brain Cancer if you're looking for more information about glioblastoma research.
No comments:
Post a Comment